Search
Cytosorbents Corp
CTSOAdd to Watchlist
0.391USD
+0.017+4.55%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
24.57MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Cytosorbents Corp is 7.00, ranking 157 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 11.00 and a low of 0.75.
Analyst Rating
Based on
1
analysts
Hold
Current Rating
2.875
Target Price
+668.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
Cytosorbents Corp
CTSO
1
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cytosorbents Corp's expected revenue for the next quarter?
Cytosorbents Corp's expected revenue is 9.35M.
What is Cytosorbents Corp's price target?
Analysts forecast that Cytosorbents Corp's price target is USD 4.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 0.75.
How have Cytosorbents CorpCTSO's recent earnings per share performed?
The market expectation was USD -0.08, while Cytosorbents CorpCTSO's earnings per share (EPS) for the previous quarter was USD -0.09. EPS for the next quarter is expected at USD -0.04.
What is the analyst rating for Cytosorbents Corp?
Based on the ratings of Cytosorbents Corp's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.